chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Hives all over body starting at the hip and spreading to legs and back also back of the arms. Extremely itchy
Extreme breast tenderness after the last 2 shots. Even now, weeks later after finishing the series they are still tender. Hurts to press on them and nipples are sensitive. I'm on the Depo shot so I dont get the typical tenderness from menstrual cycle because I no longer have one. The tenderness only began after shot 3 and shot 4 out of the series. It was the post exposure series. I was bitten by a rabies positive dog. I want to know when it will go away.
HPV #1 was administered to L arm, approximately 10-15 seconds after administration patient tried to stand and immediately lost balance, fainted for less than 5 seconds. Patient's eyes rolled back, became very limp as the MA caught him. Provider was immediately called into patient's room for examination. Patient was laying supine on exam table with eyes open when provider came into the room. Patient responsive, alert and oriented, pupils equal, round and reactive to light and accommodation, heart R&R regular, lungs CTA. Patient verbalized he felt a little dizzy and weak. Patient remained laying down, then sat up slowly when dizziness and weakness were gone. Patient sat up and drank water, at the end of the 20 minute observation patient stood up with no dizziness or weakness. Mother was contacted at the end of the day at 5:05 pm to check how patient was doing. Mother stated he was feeling better and was only complaining of a mild headache.
This non-valid, spontaneous report was received from a registered nurse, referring to an unspecified number of patients of unknown age and gender. No information was provided regarding the patients' medical history, previous drug reactions, allergies, concurrent medical conditions or concomitant medications. On unknown dates, the patients were vaccinated with improperly stored doses of LIQUID PEDVAXHIB lot number N034005 (expiration date 31-JAN-2020) and lot number reported as "N021920" (expiration date 07-FEB-2020) for prophylaxis (doses, routes and anatomical locations of administration were not reported). Additionally, the patients were vaccinated with ROTATEQ by oral route, lot number N005078 (expiration dates 22-NOV-2018 and 04-OCT-2018) for prophylaxis (doses were unknown), GARDASIL 9 lot number N020352 (expiration date 10-APR-2020) for prophylaxis (doses, routes and anatomical locations of administration were not provided) and M-M-R II for prophylaxis (dose numbers, routes and anatomical locations of administration were not provided; lot numbers N010496 [expiration date 31-MAR-2019], N014485 [expiration date 10-MAY-2019], and N023149 [expiration date 24-AUG-2019]). The vaccines were reconstituted with sterile diluent which was reported to be properly stored. The doses of all vaccines were exposed to a temperature excursion below 32 degrees Fahrenheit (F) (also reported as 31F) during a time frame of 15 days, which was detected by the Digital Data Logger. There was no prior temperature excursion and no adverse effects were reported. Follow-up information was received from the nurse on 17-DEC-2018. The reporter provided patients' demographics which made the case valid. This report refers to a 5-month-old patient of unknown gender. On 27-MAR-2018, the patient was vaccinated with an improperly stored dose of LIQUID PEDVAXHIB lot number N020352 (expiration date 31-JAN-2020). This is one of multiple reports received from the same reporter. Sender's Comments: US-009507513-1807USA011661.
Wrong dose of Fluzone Pediatric vaccine given for age group. Had Fluzone .50ml Lot number UT3251AA given instead of Influenza .25ml Fluzone vaccine lot number3478CA for 6-35 month olds. Package of older age group Fluzone 3 Yr. > was placed on top of the 6-35 month package in the refrigerator and the nurse picked up the wrong box for these two brothers.
Very sore arm for four days.  After one week a lump appeared in my arm for about four days then has started to reduce in size.
painful, itchy, rashy knot "size of an orange" developed after one week post vaccination
Day of shot within 1 hour Felt like my arm was dislocated for several days. Still feeling discomfort. Day 3 Extreme burning in lower jaw with pain also similar to toothache and all teeth and lower jaw. Eventually extended throughout my neck and lower part of my head. Inhaling felt like stabbing in lower neck and a three and four.
Vaccines went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 01-Apr-2022; Received vaccine past its 30-days Exp date; This spontaneous case was reported by an emergency medical technician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days Exp date) and PRODUCT STORAGE ERROR (Vaccines went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 01-Apr-2022) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     It was unknown if patient had any acute illnesses at the time of vaccination and up to one month before. It was unknown if the patient had chronic or long-standing health conditions. It was unknown if any prescriptions, over-the-counter-medications, dietary supplements, or herbal remedies were being taken by the patient at the time of vaccination and/or at the time of the adverse event. It was unknown if other vaccines were given on the same day as Moderna COVID-19 Vaccine to the patient. It was unknown if patient received other vaccines within one month prior to any dose of Moderna COVID-19 Vaccine.     On 01-Apr-2022 at 2:05 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 01-Apr-2022 at 2:05 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days Exp date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccines went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 01-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days Exp date) and PRODUCT STORAGE ERROR (Vaccines went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 01-Apr-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient Ethnicity: EXACT.  No concomitant medications information was reported. It was reported that patient administered with second booster. Vaccine went into 2 to 8 degree Celsius thaw state on about 24 Dec 2021. The vaccine was administered up until its manufacturing expiry date of 04 Apr 2022.  No treatment medications were provided.   This case was linked to MOD-2022-542869 (Patient Link).
3 yrs post vax, pt devel documented streptococcal pneumoniae pneumonia. Follow up on 7/27/2000 states we have no way of providing further information without patient's name.
About 15 min after administration, patient started c/o numbness/tingling in chin and lips. Patient was given oral diphenhydramine 50mg and notified EMS. When EMS arrived about 15 min  later, patient initially declined to go to ER for eval. About another 15 min later, patient returned to clinic as face and chin were starting to swell slightly. Re-notifed EMS  and the returned and picked up the patient. Patient left in awake condition, no respiratory distress.
Body aches beginning approx, 24 hours after vaccine administration-resolved without intervention. Sore throat beginning 11/10/09 - ongoing - no treatment as yet. "Tightness" in throat beginning 11/10/09 AM-no treatment-resolved without intervention after sleeping. Hoarseness of voice beginning 11/10/09 PM, after tightness in throat resolved-ongoing- no treatment as yet.
Softball-sized lump at the injection site. Instructed to try compresses and antihistamine. F/U phone call on 5/13/02; pt's leg is doing fine.
AWOKE MORNING AFTER VACCINATION WITH RIGHT EYE REDNESS AND RAISED, RED RASH EXTENDING FROM UNDER LEFT ARM ACROSS LEFT CHEST. (LEFT ARM VACCINATION).  DIAGNOSED AS SHINGLES IN ER LATE P.M. 12/10/03.  GIVEN VALACYLOVIR FIRST DOSE 12/11/03.  NO BLISTERING OR PAIN WITH RASH, OR SYMPTOMS PRIOR TO RASH ONSET, AND RASH HAS FADED CONSIDERABLY BY DAY 3 AFTER IMMUNIZATION WITH NO FURTHER SYMPTOMS.  EYE REDNESS DIAGNOSED IN ER SAME NIGHT AS CONJUNCTIVITIS.  EYE REDNESS RESOLVED WITHIN 24 HOURS WITHOUT TREATMENT.
The night I received my booster dose of Moderna Covid -19 vaccine, I couldn?t sleep due to loud and rapid heartbeat (greater than 100 beats per minute). Since the vaccine, I have pulsatile tinnitus, especially in my right ear, sounding like a swooshing with every heartbeat when I am in a quiet environment.
My baby cried inconsolably (screaming, crying hysterically despite the ibuprofen we'd given him two hours prior to help with any pain from the injection) for three and a half hours.
Sore muscle where vaccine was given.  Hurts to move arm to some positions. Pt. never had redness, swelling, fever or rash and did not have any trouble breathing immediately after the shot or anytime thereafter. Just reports sore, weak muscle from approx. two days after shot was given and continues with these symptoms today.  She works at at fast food restaurant and has not missed any work.  Pt. did not seek medical attention.  Referred to private MD and asked her to call after her appt. with diagnosis and/or treatment.
Right arm soreness and swelling after first injection; Right arm soreness and swelling after first injection; Weak and tired and stayed in bed after first injection; Weak and tired and stayed in bed after first injection; She had a difficult time sleeping on that side of the right arm after the first injection; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A 76 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 24Feb2021 (Lot number: EN6202) at the age of 76 years as dose 1, 0.3 ml single for covid-19 immunisation. The patient had no relevant medical history. The concomitant medications included blood pressure medication all the time and had for years. The following information was reported: VACCINATION SITE SWELLING (non-serious), VACCINATION SITE PAIN (non-serious) all with onset 24Feb2021, outcome "recovering" and all described as "Right arm soreness and swelling after first injection"; FATIGUE (non-serious), ASTHENIA (non-serious) all with onset 24Feb2021, outcome "recovering" and all described as "Weak and tired and stayed in bed after first injection"; LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (non-serious) with onset 2021, outcome "unknown", described as "She had a difficult time sleeping on that side of the right arm after the first injection". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: She received the vaccine at the hospital. She takes blood pressure medication all the time and had for years so it was not relevant. She did not have time to complete vaccine supplemental form. She feels awful and did with the first one. She felt weak and tired and just stayed in bed the rest of the day. She had a difficult time sleeping on that side of the right arm after the first injection and had to put cold packs on it.   No follow-up attempts are possible. No further information is expected.
swollen gums at teeth; Sore in teeth; Sore inner cheeks; Canker sores; Lower back rash; This is a spontaneous report from a contactable consumer or other non hcp.   A 66-years-old non-pregnant female patient received first dose of bnt162b2 (BNT162B2, Solution for injection, Lot Number: EL3246, expiration date: unknown), via an unspecified route of administration, administered in Arm Left on 02Feb2021 15:15 (at the age of 66 years) as dose 1, single for covid-19 immunisation.  Medical history included hypertension allergy to Penicillin. Patient did not receive any other vaccine within 4 weeks. Patient neither diagnosed with COVID-19 prior to vaccination nor been tested for COVID-19 after the vaccination. Concomitant medications included Lisinopril 10 mg. on 05Feb2021, the patient experienced swollen gums at teeth, Sore inner cheeks, Sore gums at cheek line, Canker sores and Lower back rash. At the time of report, patient was recovering from all the events.  No follow-up attempts were possible; information about lot/batch number could not been obtained.
This case was reported by a consumer via call center representative and described the occurrence of arm paralysis in a 66-year-old female patient who received SHINGRIX for prophylaxis. Previously administered products included Shingles vaccine (the patient received vaccine on an unknown date). In June 2018, the patient received SHINGRIX. In June 2018, less than a month after receiving SHINGRIX, the patient experienced arm paralysis (serious criteria GSK medically significant), fever, red blotches, swelling arm, hallucination, mobility decreased, pain in arm, sleepiness and sickness. On an unknown date, the outcome of the arm paralysis, fever, red blotches, swelling arm, hallucination, mobility decreased, pain in arm, sleepiness and sickness were unknown. It was unknown if the reporter considered the arm paralysis, fever, red blotches, swelling arm, hallucination, mobility decreased, pain in arm, sleepiness and sickness to be related to SHINGRIX. Additional details were provided as follows: This adverse event (AE) reported via click to chat. The reporter was a patient. The patient had received many vaccines with no adverse events. The patient received a new Shingles vaccine in the previous week of reporting and sick for two days. The patient also experienced fever and felt like hallucination all night. The patient's arm was paralyzed and he could not lift his arm. The arm was swelled, got red blotches and was so sore. The patient slept most of two days and had a fever.
Heavy menstrual  bleeding with cramps, menstruation increase from 4-5 days to 6-7 days. Blood per day from normal to heavy. acne severely increased. Gained egg sized breast lump in one breast
Sore arm. Sore throat. Back ache. Headache. Chills in feet
This is a spontaneous report received from a contactable Physician via Pfizer sales representative. A 72-year-old patient of an unspecified gender received PREVNAR 13, via an unspecified route of administration on an unspecified date at single dose for immunisation. Medical history included diabetes mellitus, chronic heart disease and hypertension. The patient's concomitant medications were not reported. The patient previously took pneumococcal polysaccharide vaccine, 23-valent for immunisation. The patient developed pneumococcal pneumonia few months after being vaccinated with pneumococcal 13-val conjugate vaccine (dipht crm197 protein). The outcome of the event pneumonia was unknown. No follow-up attempts are possible. No further information is expected. Information about batch number cannot be obtained.; Sender's Comments: Based on the information currently available, a lack of efficacy with pneumococcal 13-valent conjugate vaccine in this patient cannot be completely excluded.
Given Zostavax vaccine at 59 years, package insert/policy indicate vaccine to be given to those 60 years of age and older.
Mother reports child had a reaction to vaccinations. Noted redness to left deltoid area approx the size of a silver dollar no swelling noted. Mother states," On Friday it looked like a mosquito bite, on Saturday it swelled up and was red. Took to ER orders were for Tylenol and Benadryl. Mom states area is looking better." Notified clinic on 04/22/2002 at 8:45am.
Received vaccine 10/21/2002 and Dec 7 2002. Flu symptoms, aches, pains, swollen joints. On 12/08/2002 into 12/09/2002 awoke with generalized body pain admitted 12/09 -012/10 rheumotoid symptoms. W/U awful. Increase sedrate. Dx'd acute arthrytic inflammation. The 60 day report states she recovered from the acute event fro which she was hospitalized. She still had "arthritic" complaints. She continues with follow up care and does continue to (unknown) to work.  She was hospitalized in summer 03 in the midwest with fevers of unknown origin. I really don't believe that this has anything to do with vaccine but pt questioned it. Nurse follow up on 05/18/04 states: Malaise, aches, back pain, stiffness,
Headache, chills, fever up to 101.8, soreness in arm, body aches.
Vaso-Vagal syncope in the 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of SYNCOPE (Vaso-Vagal syncope in the 1st dose) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history was provided.).    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced SYNCOPE (Vaso-Vagal syncope in the 1st dose) (seriousness criterion medically significant). At the time of the report, SYNCOPE (Vaso-Vagal syncope in the 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment information for the event was provided. Patient decided not to get 2nd shot due to syncope with first dose.  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Patient legs started going out around 3 pm. Son called hospital and at ER contributed to flu vaccine (due to feverish arm) per physician (detailed by son). Patient told to have "mild, but seemingly unimportant per prescriber minor/mini heart heart attack". Patient now dong well, recovered around 1 week after the date of event.
Hard lump at injection site reappeared; Itching at injection site; rash on her left arm/ red rash on left arm reappeared; Very hard lump on injection site; redness at the injection site; Injection site rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (rash on her left arm/ red rash on left arm reappeared), INJECTION SITE MASS (Very hard lump on injection site), INJECTION SITE MASS (Hard lump at injection site reappeared), INJECTION SITE PRURITUS (Itching at injection site) and INJECTION SITE ERYTHEMA (redness at the injection site) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced INJECTION SITE MASS (Very hard lump on injection site), INJECTION SITE ERYTHEMA (redness at the injection site) and INJECTION SITE RASH (Injection site rash). On 25-Feb-2021, the patient experienced RASH ERYTHEMATOUS (rash on her left arm/ red rash on left arm reappeared), INJECTION SITE MASS (Hard lump at injection site reappeared) and INJECTION SITE PRURITUS (Itching at injection site). The patient was treated with HYDROCORTISONE at an unspecified dose and frequency. At the time of the report, RASH ERYTHEMATOUS (rash on her left arm/ red rash on left arm reappeared), INJECTION SITE MASS (Hard lump at injection site reappeared) and INJECTION SITE PRURITUS (Itching at injection site) had not resolved and INJECTION SITE MASS (Very hard lump on injection site), INJECTION SITE ERYTHEMA (redness at the injection site) and INJECTION SITE RASH (Injection site rash) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.
One month after my booster vaccine, I experienced tinnitus and on or around 03/2022 I started to experience an inflamed ganglion to my left side of the neck, carotid area. They did a U/S of the neck and found a ganglion cyst, left side carotid region. I will be undergoing a CT scan of the neck with contrast is pending and I am scheduled to see my PCP on 05/20/2022. My PCP has suggested at this time to not get my 4th vaccine yet. I could not provide my lot number not documented on vaccine card.
she tested positive for COVID; she tested positive for COVID; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team and product quality group, Program ID. The reporter is the patient.  A 70-year-old female patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 09Nov2023 at 10:15 as dose 1, single (Lot number: HF9298) at the age of 70 years, in left arm for covid-19 immunisation; influenza vaccine (INFLUENZA VACCINE), on 27Oct2023 as dose 2, single (Batch/Lot number: unknown). The patient's relevant medical history included: "High Blood Pressure" (ongoing), notes: High Blood Pressure; "Cholesterol" (ongoing). Concomitant medication(s) included: LISINOPRIL taken for hypertension. Vaccination history included: Bnt162b2 (Dose 1, LOT#: EL9262), administration date: Jan2021, when the patient was 67 years old, for COVID-19 immunization; Bnt162b2 (Dose 2, LOT#: EN6199), administration date: Jul2022, when the patient was 69 years old, for COVID-19 immunization, reaction(s): "had no problem at all"; Flu shot (Dose 1), administration date: Jul2022, when the patient was 69 years old, for immunization, reaction(s): "had no problem at all". The patient had never had Covid. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 12Nov2023, outcome "recovering" and all described as "she tested positive for COVID". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (14Nov2023) positive, notes: tested positive for COVID. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: The patient took Lisinopril for High blood pressure which it was under control she took something for Cholesterol. She received Comirnaty booster, the newest formulation on last Thursday (09Nov2023), and on Sunday night (12Nov2023) she started feeling chills and got tired, by Monday (13Nov2023), she came up with all of them (headache, diarrhea, fever, chills, upset stomach, cough), then on Tuesday (14Nov2023), she tested herself in which she was positive for COVID. she had no idea how she would have gotten COVID as they did everything outside. She went to church inside and was recently exposed to someone who had pneumonia, and she didn't go around big groups of people and they were very careful. She had been prescribed Paxlovid, however she wasn't going to take it as she wasn't getting worse, and was only getting better or maintaining. The patient had taken Mucinac (usually took three times a day, took at 6:30 in the morning then at like 3:30 in the afternoon and then took later on before went to bed at around eleven, three capsules, three times a day), Tylenol and Advil for treatment. Mucinac took two and today (16Nov2023), she cut it back to one because some of them was giving her horrible diarrhea and she did not know what that was.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300380669 Same patient/drug, different dose/event;